Summary
Pfizer Inc. filed an 8-K on April 28, 2015, reporting the outcomes of its Annual Meeting of Shareholders held on April 23, 2015. The primary focus of the filing is the voting results on key corporate matters, including the election of directors, ratification of the independent auditor, and executive compensation. All director nominees received overwhelming support for re-election. Additionally, shareholders ratified KPMG LLP as the independent registered public accounting firm for the 2015 fiscal year and approved, on an advisory basis, the compensation of the company's Named Executive Officers. A shareholder proposal regarding lobbying activities, however, did not receive majority approval. This report provides transparency on shareholder sentiment and corporate governance at Pfizer.
Key Highlights
- 1All director nominees were overwhelmingly elected to the Board of Directors, receiving substantial 'For' votes.
- 2Shareholders ratified the appointment of KPMG LLP as Pfizer's independent registered public accounting firm for fiscal year 2015.
- 3The 'Say-on-Pay' proposal, approving executive compensation on an advisory basis, was passed by shareholders.
- 4A shareholder proposal requesting a report on lobbying activities was not approved.
- 5The filing confirms the date of the Annual Meeting of Shareholders as April 23, 2015.
- 6High levels of shareholder participation are indicated by the significant number of votes cast, including broker non-votes, for each proposal.